✦ LIBER ✦

188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study

✍ Scribed by Marnix G. E. H. Lam; Tjitske B. Bosma; Peter P. van Rijk; Bernard A. Zonnenberg

Publisher: Springer
Year: 2009
Tongue: English
Weight: 229 KB
Volume: 36
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-009-1119-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined use of zoledronic acid and 153S

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

A phase I/II study of continuous infusio

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response

✍ C. J. Bowden; W. D. Figg; N. A. Dawson; O. Sartor; R. J. Bitton; M. S. Weinberge 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

A phase 2 study of high-activity186Re-HE

A phase 2 study of high-activity186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone

✍ J. M. O’Sullivan; A. R. Norman; V. R. McCready; G. Flux; F. M. Buffa; B. Johnson 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 155 KB

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

A phase I study of the somatostatin anal

A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer

✍ William D. Figg; Alain Thibault; Michael R. Cooper; Robert Reid; Donna Headlee; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

A Phase I/II study of strontium-89 combi

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

✍ Lance C. Pagliaro; Ebrahim S. Delpassand; Dallas Williams; Randall E. Millikan; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the maximum tolerated dose and to evaluate the efficacy of gemcitabine given in combination with strontium‐89 to patients with androgen independent prostate carcinoma. ## METHODS Patients with androgen‐independent pr